5 FTSE Stocks Fools Think Will Lead the Next Bull Market
Image source: Getty Images Will these FTSE stocks be among the biggest winners in the next rally? These five fools are confident! AstraZeneca What it does: AstraZeneca is a global biopharmaceutical company specializing in oncology, rare diseases, cardiovascular disease and…
Chief Business Officer Gregory Weinhoff sells 30,000 shares of Centessa …
On August 23, 2024, Gregory Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), performed a significant transaction by selling 30,000 shares of the company’s stock. The sale was documented in a recent SEC filing. Following this transaction, the…
High-growth tech stocks to watch in Hong Kong in August 2024
The Hong Kong market has seen a remarkable rebound, with the Hang Seng Index rising 1.99% amid mixed economic signals from China. As global markets show signs of recovery and investor sentiment improves, it is crucial to identify high-growth technology…
Director of Operations and Science …
On August 20, 2024, Steve Miller, Chief Operating & Scientific Officer of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), sold 150,000 shares of the company. The transaction was documented in a recent SEC filing. After this sale, the insider now owns 675,124 shares…
Upcoming Stock Splits This Week (August 19-23) – Stay Invested
These are the upcoming stock splits for the week of August 19-23, based on TipRanks’ stock split calendar. A stock split is a corporate action in which the company issues additional common shares to increase the number of shares outstanding….
High-growth tech stocks in South Korea you should know
Over the past 7 days, the South Korean market is up 4.1%, driven by 8.2% gains in information technology. Over the past year, it is up 5.1%. With earnings expected to grow 28% annually, identifying high-growth technology stocks that fit…
Phathom Pharmaceuticals Announces Pricing of $130 Million Common Stock and Pre-Funded Warrants Offering
Phathom Pharma FLORHAM PARK, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced the pricing of its underwritten offering of 8,695,652 shares…
CFO Mark Hahn sells 400,000 shares of Verona Pharma PLC (VRNA)
Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (NASDAQ:VRNA), conducted a significant transaction on August 13, 2024, in which the insider sold 400,000 shares of the company’s stock. The sale was documented in a recent SEC filing. Following…
Chief People Strategy Officer Schaeffer Orlov S Nicole sells shares to Insmed Inc …
On August 12, 2024, Schaeffer Orlov S Nicole, Chief People Strategy Officer, sold 9,469 shares of Insmed Inc (NASDAQ:INSM) at a price of $72.49 per share. The transaction was documented in a recent SEC filing. Following this sale, the insider…
CEO Richard Gonzalez sells 66,500 shares of AbbVie Inc (ABBV)
On August 5, 2024, Richard Gonzalez, CEO of AbbVie Inc (NYSE:ABBV), sold 66,500 shares of the company. The transaction was documented in a recent SEC filing. After this sale, the insider now owns 446,599 shares of AbbVie Inc. AbbVie Inc…
